Drug that cuts breast cancer risk set for wider use in UK
An oral medicine called anastrozole has been approved by the UK's drug regulatory agency for reducing the risk of breast cancer in post-menopausal women at moderate-to-high risk of the condition
An oral medicine called anastrozole has been approved by the UK's drug regulatory agency for reducing the risk of breast cancer in post-menopausal women at moderate-to-high risk of the condition
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
